CEC Capital advises Zhongkexinyang on 100-million-yuan private financing roundPUBT·2 days ago, 07:09 PM
VTR released its performance for the first three quarters, with a net profit attributable to the parent company of 18.2044 million yuan, a decrease of 57.47%Zhitong·Oct 28, 2025 at 09:54 AM300381+1.78%
VTR: The company has currently stopped the production of Vitamin B12Zhitong·Sep 20, 2025 at 02:16 AM300381+1.78%
HAID GROUP, VTR and other newly established biotechnology companiesZhitong·Sep 11, 2025 at 10:21 PM002311+0.43%300381+1.78%
VTR: Net profit of 13.997 million yuan in the first half of 2025, a year-on-year decrease of 66.50%Zhitong·Aug 27, 2025 at 07:43 AM300381+1.78%
VTR released its first-quarter results, with a net profit attributable to the parent company of 4.8705 million yuan, a year-on-year decrease of 75.19%Zhitong·Apr 22, 2025 at 03:17 AM300381+1.78%
VTR released its 2024 annual performance, turning a loss into a profit of 31.0919 million yuanZhitong·Apr 18, 2025 at 09:28 AM300381+1.78%
VTR: Shareholder dividend return plan for the next three yearsZhitong·Apr 18, 2025 at 08:15 AM300381+1.78%
VTR plans to invest 230 million yuan in the construction project of VTR Innovation ParkZhitong·Mar 2, 2025 at 02:47 AM300381+1.78%
VTR and other investors establish a new biotechnology companyZhitong·Feb 25, 2025 at 07:51 PM300381+1.78%
